These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33459728)

  • 1. State-of-the-art overview on biological treatment for CRSwNP.
    Hellings PW; Verhoeven E; Fokkens WJ
    Rhinology; 2021 Apr; 59(2):151-163. PubMed ID: 33459728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis.
    Miglani A; Soler ZM; Smith TL; Mace JC; Schlosser RJ
    Int Forum Allergy Rhinol; 2023 Feb; 13(2):116-128. PubMed ID: 35980852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
    Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye.
    Demir M; Tunakan Dalgic C; Mete Gokmen EN; Savas R; Eroglu S; Ozden G; Orcen C; Pacaci Cetin G; Arslan B; Bilgir F; Bulut G; Akcam NY; Ozgul S; Cerci P; Coskun R; Gode S; Yilmaz I; Sin AZ
    Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541174
    [No Abstract]   [Full Text] [Related]  

  • 5. Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
    Gevaert P; Mullol J; Saenz R; Ko J; Steinke JW; Millette LA; Meltzer EO
    Ann Allergy Asthma Immunol; 2024 Mar; 132(3):355-362.e1. PubMed ID: 37951571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiological Versus Clinical 1-Year Outcomes of Dupilumab in Refractory CRSwNP: A Real-Life Study.
    Giombi F; Pace GM; Nappi E; Giunta G; Muci G; Pirola F; Ferreli F; Heffler E; Paoletti G; Giannitto C; Mercante G; Francone M; Spriano G; Canonica GW; Malvezzi L
    Laryngoscope; 2024 Jun; 134(6):2626-2633. PubMed ID: 38126613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy.
    Papacharalampous GX; Constantinidis J; Fotiadis G; Zhang N; Bachert C; Katotomichelakis M
    Int Forum Allergy Rhinol; 2024 Jan; 14(1):96-109. PubMed ID: 37394893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 Biomarkers for the Indication and Response to Biologics in CRSwNP.
    Guo CL; Liu FF; Wang DY; Liu Z
    Curr Allergy Asthma Rep; 2023 Dec; 23(12):703-713. PubMed ID: 37987873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omalizumab Treatment in Uncontrolled Asthma and CRSwNP Patients, with Previous Endoscopic Sinus Surgery, to Improve Quality of Life and Endoscopic Outcomes: a Two-Year Real-Life Study.
    Maza-Solano J; Callejon-Leblic A; Martin-Jimenez D; Moreno-Luna R; Gonzalez-Garcia J; Cuvillo A; Sanchez-Gomez S
    Curr Allergy Asthma Rep; 2023 Oct; 23(10):555-566. PubMed ID: 37644255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review.
    Rahavi-Ezabadi S; Zhou S; Lee SE; Ference E; Magit A; Leuin S; Mohamed K; Rezaei N; Patel VA
    Otolaryngol Head Neck Surg; 2024 Jul; 171(1):35-44. PubMed ID: 38488239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP.
    Rosso C; De Corso E; Conti V; Nitro L; Saibene AM; Parazzini E; Rinaldo R; De Pascalis S; Arnone F; Centanni S; Montuori C; D'Auria LM; Felisati G; Pipolo C
    Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3017-3023. PubMed ID: 38347197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of sinus opacification, olfaction and dupilumab efficacy in patients with CRSwNP.
    Lee SE; Amin N; Mannent LP; Bachert C; Gross G; Cho SH; Praestgaard A; Siddiqui S; Nash S; Kamat S; Khan AH; Jacob Nara JA
    Rhinology; 2023 Dec; 61(6):531-540. PubMed ID: 37453138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy.
    Maniaci A; Saibene AM; Calvo-Henriquez C; Vaira L; Radulesco T; Michel J; Chiesa-Estomba C; Sowerby L; Lobo Duro D; Mayo-Yanez M; Maza-Solano J; Lechien JR; La Mantia I; Cocuzza S
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):2167-2173. PubMed ID: 38329526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep quality burden in chronic rhinosinusitis with nasal polyps and its modulation by dupilumab.
    Ferri S; Montagna C; Casini M; Malvezzi L; Pirola F; Russo E; Racca F; Messina MR; Puggioni F; Nappi E; Costanzo G; Del Moro L; Mercante G; Spriano G; Canonica GW; Paoletti G; Heffler E
    Ann Allergy Asthma Immunol; 2024 Jan; 132(1):69-75. PubMed ID: 37652235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mepolizumab improves sense of smell in severe chronic rhinosinusitis with nasal polyps: SYNAPSE.
    Mullol J; Lund VJ; Wagenmann M; Han JK; Sousa AN; Smith SG; Mayer B; Chan RH; Fokkens WJ
    Rhinology; 2024 Jun; 62(3):320-329. PubMed ID: 38217844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps: An analysis of randomized clinical trials.
    Meltzer EO; Mullol J; Ko J; Saenz R; Steinke JW; Millette LA; Gevaert P
    Int Forum Allergy Rhinol; 2024 Jul; 14(7):1163-1172. PubMed ID: 38197558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dupilumab's impact on nasal citology: Real life experience after 1 year of treatment.
    Gelardi M; Giancaspro R; Quaranta VN; La Gatta E; Ruzza A; Cassano M
    Am J Otolaryngol; 2024; 45(4):104275. PubMed ID: 38574514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "real life" efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP.
    Campion NJ; Brugger J; Tu A; Stanek V; Brkic FF; Bartosik TJ; Liu DT; Hoehl BS; Gangl K; Eckl-Dorna J; Schneider S
    J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):56. PubMed ID: 37674253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab: Real-World Use and Outcomes.
    Schmale IL; Poulakis A; Abend A; Luitje ME; Man LX
    J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3203-3210. PubMed ID: 37543087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe chronic rhinosinusitis treated with dupilumab, a real-life analysis of early effectiveness.
    Mocellin D; Ioppi A; Gaglio G; Pennacchi A; Bertolini M; Tirrito A; Guastini L; Bagnasco D; Passalacqua G; Peretti G; Canevari FRM
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7324-7336. PubMed ID: 37606141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.